Pregabalin vs. Gabapentin on Reducing Opioid Usage
Launched by CAMC HEALTH SYSTEM · Jan 8, 2021
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how well two medications, Pregabalin and Gabapentin, work alongside traditional opioid pain medications to help reduce the amount of opioids needed for patients recovering from orthopedic trauma, which involves injuries to bones and joints. The aim is to see if these medications can help manage pain effectively while allowing patients to use fewer opioids, which can help prevent potential issues related to opioid use.
To participate in this trial, you need to be at least 18 years old and have been admitted to the hospital for treatment of an orthopedic injury. You should also have an active prescription for opioids when you join the study. If you meet these criteria, you may be included in the research. If you enroll, you can expect to receive either Pregabalin or Gabapentin in addition to your usual pain medication during your hospital stay. This study is currently recruiting participants, and it’s important to note that some patients may not be eligible based on certain medical conditions or treatments they are receiving.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Nurse Practitioner service admissions
- • 2. 18 years of age or older
- • 3. Patients enrolled within 36 hours of admission
- • 4. Anticipated duration of hospitalization \> 24 hours from time of consent
- • 5. Active order(s) for opioids in place at the time of enrollment
- Exclusion Criteria:
- • 1. Clinician discretion based on patient care management
- • 2. Intubated patients
- • 3. Patients with epidural
- • 4. Patients with pregabalin/gabapentin as home medications
- • 5. Patients receiving pregabalin/gabapentin upon admission
- • 6. Traumatic brain injury patients
- • 7. CrCl\<30ml/min or on HD
- • 8. Unable to take enteral medications
- • 9. On Patient Controlled Analgesia (PCA)
- • 10. Patients with complicated wound closure
- • 11. History of epilepsy
- • 12. Documented history of substance use disorder
About Camc Health System
CAMC Health System is a comprehensive healthcare organization based in Charleston, West Virginia, dedicated to enhancing patient care through innovative clinical research and trials. As a leading sponsor of clinical studies, CAMC Health System focuses on advancing medical knowledge and treatment options across various specialties, including cardiology, oncology, and neurology. With a commitment to ethical standards, patient safety, and community health, CAMC collaborates with researchers and healthcare professionals to facilitate groundbreaking studies that aim to improve health outcomes and quality of life for patients both locally and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, West Virginia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials